...
首页> 外文期刊>Biochemistry >13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
【24h】

13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.

机译:13 C NMR研究枯草杆菌蛋白酶和胰凝乳蛋白酶四面体加合物的氧阴离子pKa值如何受到酶亚基S1-S4中不同氨基酸残基结合的影响。

获取原文
获取原文并翻译 | 示例

摘要

A range of substrate-derived chloromethane inhibitors have been synthesized which have one to four amino acid residues. These have been used to inhibit both subtilisin and chymotrypsin. Using 13C NMR, we have shown that all except one of these inhibitors forms a tetrahedral adduct with chymotrypsin, subtilisin, and trypsin. From the pH-dependent changes in the chemical shift of the hemiketal carbon of the tetrahedral adduct, we are able to determine the oxyanion pKa in the different inhibitor derivatives. Our results suggest that in both the subtilisin and chymotrypsin chloromethane derivatives the oxyanion pKa is largely determined by the type of amino acid residue occupying the S1, subsite while binding in the S2-S4 subsites only has minor effects on oxyanion pKa values. Using free energy relationships, we determine that the different R groups of the amino acid residues binding in the S1 subsite only have minor effects on the oxyanion pKa values. We propose that the lower polarity of the chymotrypsin active site relative to that of the subtilisin active site explains why the oxyanion pKa is higher and more sensitive to the type of chloromethane inhibitor used in the chymotrypsin derivatives than in the subtilisin derivatives.
机译:已合成了一系列具有一至四个氨基酸残基的底物衍生的氯甲烷抑制剂。这些已被用来抑制枯草杆菌蛋白酶和胰凝乳蛋白酶。使用13 C NMR,我们显示除这些抑制剂中的一种外,所有其他抑制剂均与胰凝乳蛋白酶,枯草杆菌蛋白酶和胰蛋白酶形成四面体加合物。从pH依赖的四面体加成物的半缩碳的化学位移变化,我们能够确定不同抑制剂衍生物中的氧阴离子pKa。我们的结果表明,在枯草杆菌蛋白酶和胰凝乳蛋白酶氯甲烷衍生物中,氧阴离子pKa在很大程度上取决于占据S1亚位点的氨基酸残基的类型,而结合在S2-S4亚位点上对氧阴离子pKa值的影响很小。使用自由能关系,我们确定在S1亚位点结合的氨基酸残基的不同R基团对氧阴离子pKa值的影响很小。我们提出,相对于枯草杆菌蛋白酶活性位点而言,胰凝乳蛋白酶活性位点的极性较低,这解释了为什么含氧阴离子pKa比在枯草杆菌蛋白酶衍生物中对胰凝乳蛋白酶衍生物中使用的氯甲烷抑制剂类型更高且更敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号